DXCM Q3 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$975M+26.7% YoY

Gross Profit

$623M63.9% margin

Operating Income

$206M21.1% margin

Net Income

$121M12.4% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

$269M

Free Cash Flow

$219M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$6.6B

Total Liabilities

$4.3B

Stockholders' Equity

$2.3B

Cash & Equivalents

$644M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$975M	$770M	+26.7%
Gross Profit	$623M	$494M	+26.1%
Operating Income	$206M	$148M	+39.3%
Net Income	$121M	$101M	+19.3%

Geographic Segments

UNITED STATES

$714M73%

Non-US

$261M27%